DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
The Future of Pain Relief Through Wearable Tech: Electrical Stimulation, Ultrasound, and AI Poised to Transform Chronic and Everyday Pain Management
AOL/BGR (February 5, 2026, by Talia Roepel) reported on how wearable health technology is poised to transform the future of pain relief, offering drug-free alternatives at a time when opioid addiction remains a major public health concern. The article highlights two key devices: Hinge Health's Enso, an adhesive-style transcutaneous electrical nerve stimulator (TENS) that delivers electrical impulses to target joint and muscle pain and allows users to control signal intensity via an app; a clinical trial found that Enso users experienced a 54.7% decrease in pain after four weeks of use, with improvements in mobility and walking speed also reported. The second device is the ultrasound-induced wireless implantable (UIWI) stimulator developed by the Zhou Lab at USC Viterbi's Alfred E. Mann Department of Biomedical Engineering—a flexible band that uses an AI algorithm to classify pain intensity based on brain signals and then stimulates the spinal cord with electrical pulses to block pain; researchers are working toward less invasive implantation or fully external application. A 2022 study in The Clinical Journal of Pain following hundreds of chronic pain patients over a year found that wearable tech may positively impact depression and reduce reliance on prescribed morphine. According to a Nature editorial, wearable health technology is already beginning to influence clinical practice, with advances in flexible materials, sensors, and AI enabling management of chronic conditions outside the clinic. Data security, accessibility, and limited data quality remain challenges that must be overcome before widespread adoption.
Avia and Duke University Engineering Program Collaborate on Research of Mobile Games and Cognitive Health in Aging Populations
AviaGames, an award-winning mobile games developer, announced on March 9, 2026, a new research collaboration with Duke University's Pratt School of Engineering and its Product Lab, focusing on the potential for skill-based mobile games to support cognitive engagement and healthy aging. The study centers on Avia's popular title Solitaire Clash—which has surpassed 60 million total downloads and hosts 450 million monthly tournaments—examining how structured, skill-based gameplay may support sustained attention, decision-making, motivation, and social connection among older players. Through May 2026, a Duke engineering student team will conduct structured interviews and research synthesis analyzing player trends and behavior in Solitaire Clash. As millions of adults increasingly turn to mobile games for entertainment and mental stimulation, the research aims to better understand how thoughtfully designed digital play could shape broader conversations around aging. Avia CEO and Founder Vickie Yanjuan Chen stated the collaboration deepens understanding of the player community while supporting research-driven conversations about mobile gaming's social applications. Duke's Anna Wilson, Executive in Residence at the Pratt School, noted that partnering with an established company brings valuable real-world learning experience to students, with goals including game-design prototyping that contributes to understanding of interactive social play and engagement in aging.
Scent Technology Gains Recognition in Military Training
SensoryCo has been recognized as the “Top Military Scenting System 2026” by Aerospace and Defense Review for its scent generator technology used in military and law enforcement training simulations. This technology aims to improve recognition and response skills by signaling hazards such as electrical fires, smoke, fuel leaks, or weapon discharge through scent before visual confirmation. SensoryCo's systems are deployable across simulators, live exercises, and multi-zone facilities, with products like SMX-M, SMX2, and SMXT1 supporting close-range, portable, and large-scale scent delivery for scenario-based training applications.
New Evaluation Platform for ALS Treatment Drug Development Advances to Corporate Collaboration Phase
Toray Industries, Inc. announced the launch of a new collaborative initiative aimed at creating treatments for amyotrophic lateral sclerosis (ALS). This effort centers on the “patient iPS cell-derived drug efficacy evaluation technology” jointly developed by Toray and Aichi Medical University, aiming to accelerate drug discovery research through open innovation with pharmaceutical companies.
ALS is a designated intractable disease characterized by progressive muscle weakness due to motor neuron degeneration, with an average life expectancy of 3 to 5 years after onset. While over 150 candidate compounds have advanced to clinical trials, only a very limited number of drugs have been approved. The diversity of disease states and the difficulty in establishing appropriate experimental models have hindered drug discovery efficiency, making the establishment of high-precision screening technologies that reflect the disease state a key challenge.
With support from AMED, the two parties built a platform based on the culture technology of motor neurons derived from patient iPS cells, which reflect the diverse pathologies of ALS. This platform is expected to enable highly accurate evaluation and prediction of the efficacy of new drug candidate substances. It is anticipated to improve drug discovery success rates, reduce development risks, and shorten research and development periods.
Toray will now proceed with establishing evaluation facilities and operational processes while beginning to accept collaborative drug discovery research involving compounds under investigation by pharmaceutical companies. Mr. Arai of Toray Pharmaceutical Research Laboratories, who led the development, stated, “This platform aims for efficient and rapid candidate compound screening through drug efficacy evaluation under conditions close to clinical settings. Its ability to cover multiple disease states also enables disease-specific efficacy evaluation, making it a potential foundational technology for ALS drug discovery.” Expectations are high for future developments, as this patient-derived cell-based evaluation technology could become a new standard that increases the success probability of ALS drug discovery.
The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies
The Blood Center in New Orleans has modernized its platelet processing by adopting Terumo Blood and Cell Technologies' FDA-cleared Reveos™ Automated Blood Processing System and Lumia™ Software Platform. This makes it the second U.S. blood center to implement Reveos, which automates whole blood separation into platelets, plasma, and red blood cells in a single centrifugation cycle. The technology addresses U.S. platelet shortages and staffing constraints by enabling faster, more efficient, and consistent production of whole blood-derived platelets, reducing manual steps, improving product consistency, and cutting waste, ultimately strengthening the blood supply for over 50 hospitals.
Anzen Industries Raises $1.7 Million in Pre-Seed Funding for Cell-Free Biomanufacturing
Anzen Industries has secured £1.7 million ($2.2 million) in pre-seed funding to accelerate the development and commercialization of its innovative cell-free biomanufacturing platform for producing high-value chemicals. Unlike traditional methods that rely on living cells, Anzen's approach uses enzyme systems operating outside of cells. This technology aims to revolutionize the production of pharmaceuticals, diagnostics, and other industrial products, enabling faster and more cost-effective manufacturing processes.
Researchers' sweat-based sensor may help improve sleep quality
Researchers at the University of Texas at Dallas, in partnership with Texas-based biotech company EnLiSense, have developed a pioneering wearable perspiration-based sensor that measures two key hormones regulating the body's sleep-wake cycle. This electrochemical sensor continuously monitors cortisol (promoting wakefulness) and melatonin (signaling sleep). This technology offers a new approach to objectively improve sleep quality by continuously measuring hormone levels through passive sweat, overcoming the inconvenience of traditional salivary sample monitoring. EnLiSense's CORTI wearable device contributes to circadian rhythm monitoring, providing a scalable platform that allows for confident transfer of laboratory-developed processes to clinical manufacturing.
Anti-Aging Skincare Targeting Aging-Related Genes
OneSkin is a company that develops topical skincare products with high concentrations of peptides. Its diverse product line ranges from daily serums to scalp care and sunscreen, aiming to maintain skin health and improve anti-aging care by enhancing cellular function, promoting collagen production, and suppressing inflammation.
New Functional Sugar Ingredients Expanding in the Oral Care Market: A New Approach to Suppressing Plaque Formation
Wellneo Sugar is advancing the development of “CI-Dextran mix,” a functional material for oral care. This material is an oligosaccharide (CI: cyclodextran) formed by glucose molecules linked in a ring structure. Its unique molecular structure inhibits the formation of dental plaque, a cause of tooth decay and periodontal disease.
Plaque forms when cavity-causing bacteria and periodontal disease bacteria synthesize insoluble glucans using sugar as a substrate. CI-Dextran mix is characterized by its ability to create an environment where plaque itself is less likely to form by inhibiting the activity of the enzyme (GTF) these bacteria utilize. This mechanism creates an environment where bacteria cannot utilize sugar, rather than simply killing them, and its effectiveness has been confirmed even in the presence of sugar. Its efficacy has already been demonstrated in clinical trials and other studies.
Cyclodextran was discovered in 1993 as a high-functionality oligosaccharide derived from microorganisms, but mass production proved difficult, delaying its practical application for a long time. Wellnessugar acquired the rights to this technology about 10 years ago and has been advancing the establishment of mass production technology through the development of its own manufacturing process.
Its key feature is maintaining functionality even when combined with sugar. It is expected to be applied in confectionery and beverages that balance functionality and taste, with inquiries already increasing from European and Asian markets.
Mr. Hikaru Kato, responsible for development, states, “Following the first generation focused on sterilization and the second generation targeting metabolic inhibition, this material represents the ‘third generation’ of oral care ingredients by suppressing plaque formation itself. Its strengths lie in being naturally derived, low-irritation, yet possessing high functionality.” As a functional ingredient originating from a sugar manufacturer, whether CI-Dextran mix will lead to the creation of new markets spanning oral care and food sectors is a development to watch.
Alzheimer’s: a groundbreaking experiment reveals a direct link to the microbiome
A groundbreaking study published in *Brain* reveals a direct link between the gut microbiome and Alzheimer's disease. Researchers successfully transferred Alzheimer's symptoms to healthy rats by transplanting gut bacteria from affected patients. This experiment, led by an international team, identified specific bacteria like *Coprococcus* (reduced in patients) and *Desulfovibrio* (increased), positioning the gut microbiome as a major risk factor. The findings suggest new avenues for early diagnosis, prevention through microbiome modulation, and neurogenesis-based therapies to combat cognitive decline by influencing the brain's ability to generate new neurons.
Non-invasive biological data acquisition through the retina for evaluating age-related diseases
Occuity is a UK-based medical technology company developing non-contact optical measurement devices. It provides handheld devices that use light to measure intraocular structures, enabling the detection and monitoring of chronic diseases. These devices are characterized by their applicability not only for ophthalmologists and optometrists during examinations but also for screening diseases such as diabetes and Alzheimer's. Founded in 2019, the company operates from its base in Berkshire, England. It is gaining attention as a next-generation health monitoring technology, viewing the eye as a “window to overall health.”
Noninvasive imaging could replace finger pricks for people with diabetes
A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day.
The MIT team used Raman spectroscopy — a technique that reveals the chemical composition of tissues by shining near-infrared or visible light on them — to develop a shoebox-sized device that can measure blood glucose levels without any needles.
In tests in a healthy volunteer, the researchers found that the measurements from their device were similar to those obtained by commercial continuous glucose monitoring sensors that require a wire to be implanted under the skin. While the device presented in this study is too large to be used as a wearable sensor, the researchers have since developed a wearable version that they are now testing in a small clinical study.
New sensor uses microneedles to confirm fish freshness in just two minutes
Checking whether fish is fresh has traditionally meant relying on appearance and smell.